Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
This week's episode of "The Top Line" features a discussion about what’s working now in biotech and what isn't.
Recorded Oct. 7 at Fierce Biotech Week, this panel featuring leaders from past Fierce 15 winners digs into timelines, partnerships, what's hype, what's signal and how teams are pressure-testing their models in today's market.
You'll hear from Generate Biomedicines CEO Mike Nally, Arbor Biotechnologies Chief Scientific Officer John Murphy, Epicrispr Biotechnologies CEO Amber Salzman, Ph.D., and Parabilis Medicines Chief Business Officer Greg Miller. The conversation was moderated by Fierce Biotech's Gabrielle Masson.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
Fierce Biotech's 2022 Fierce 15
fiercebiotech.comFierce Biotech's 2023 Fierce 15
fiercebiotech.comomnystudio.com/listener
omnystudio.com